The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of FOLFOX plus regorafenib (REGO) in patients with unresectable or metastatic esophagogastric (EG) cancer.
 
Yelena Yuriy Janjigian
Consulting or Advisory Role - Lilly
Research Funding - Bayer; Boehringer Ingelheim
 
Geoffrey Yuyat Ku
Research Funding - Amgen; Bristol-Myers Squibb
Travel, Accommodations, Expenses - Amgen
 
Joanne F. Chou
No Relationships to Disclose
 
Marinela Capanu
No Relationships to Disclose
 
Marisa Siebel
No Relationships to Disclose
 
Sree Bhavani Chalasani
No Relationships to Disclose
 
Michelle S. Boyar
No Relationships to Disclose
 
Zoe Goldberg
No Relationships to Disclose
 
Avni Mukund Desai
No Relationships to Disclose
 
David Paul Kelsen
No Relationships to Disclose
 
Tooba Imtiaz
No Relationships to Disclose
 
David H. Ilson
Consulting or Advisory Role - Amgen; Lilly/ImClone; Roche/Genentech
Speakers' Bureau - Genentech/Roche
Research Funding - Amgen; Bayer; Bristol-Myers Squibb
Travel, Accommodations, Expenses - Amgen; Genentech/Roche